Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01975792 · ClinicalTrials.gov registry record
Fetal Thymus Involution as a Predictor of Adverse Neonatal Outcomes
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 125
- Enrollment target
NCT01975792: Completed study, sponsored by University of Pennsylvania.
NCT01975792 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01975792 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
The thymus gland is a specialized organ in the chest that plays a central role in the adaptive immune system throughout development until puberty. In response to stress, the fetal thymus gland may shrink, or involute. The investigators propose a prospective cohort study that will enroll pregnant women admitted to labor and delivery for the management of preterm labor and/or preterm premature rupture of membranes from 28-36 weeks gestation. Based on sonographic thymus measurements, the investigators will develop a clinical prediction tool to identify babies who are at increased risk for adverse neonatal outcomes. A reliable non-invasive predictor of adverse neonatal outcome using thymic ultrasound measurements has the potential to affect clinical management, improve outcomes for premature babies, and direct further research efforts.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01975792
The ClinicalTrials.gov registry entry for NCT01975792 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01975792 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01975792 about?
NCT01975792 is a clinical study titled "Fetal Thymus Involution as a Predictor of Adverse Neonatal Outcomes". The thymus gland is a specialized organ in the chest that plays a central role in the adaptive immune system throughout development until puberty. In response to stress, the fetal thymus gland may shrink, or involute. The investigators propose a prospective cohort study that will enroll pregnant wom...
What is the current status of trial NCT01975792?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2013-03. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT01975792?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.